{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:52:06Z","timestamp":1774291926914,"version":"3.50.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s40257-022-00718-8","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T08:08:25Z","timestamp":1660291705000},"page":"853-867","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Treatments for Non-Syndromic Inherited Ichthyosis, Including Emergent Pathogenesis-Related Therapy"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7775-2695","authenticated-orcid":false,"given":"Divina Justina","family":"Hasbani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0243-3921","authenticated-orcid":false,"given":"Lamiaa","family":"Hamie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9355-2474","authenticated-orcid":false,"given":"Edward","family":"Eid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christel","family":"Tamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6970-8056","authenticated-orcid":false,"given":"Ossama","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1011-0687","authenticated-orcid":false,"given":"Mazen","family":"Kurban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"issue":"4","key":"718_CR1","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jaad.2009.11.020","volume":"63","author":"VMD Oji","year":"2010","unstructured":"Oji VMD, Tadini GMD, Akiyama MMDP, Blanchet Bardon CMD, Bodemer CMDP, Bourrat EMD, et al. Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sor\u00e8ze 2009. J Am Acad Dermatol. 2010;63(4):607\u201341. https:\/\/doi.org\/10.1016\/j.jaad.2009.11.020.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"718_CR2","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/bjd.17203","volume":"180","author":"J Mazereeuw-Hautier","year":"2019","unstructured":"Mazereeuw-Hautier J, Vahlquist A, Traupe H, Bygum A, Amaro C, Aldwin M, et al. Management of congenital ichthyoses: European guidelines of care, part one. Br J Dermatol. 2019;180(2):272\u201381. https:\/\/doi.org\/10.1111\/bjd.17203.","journal-title":"Br J Dermatol"},{"issue":"3","key":"718_CR3","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2340\/00015555-1955","volume":"95","author":"I Dreyfus","year":"2015","unstructured":"Dreyfus I, Pauwels C, Bourrat E, Bursztejn A-C, Maruani A, Chiaverini C, et al. Burden of inherited ichthyosis: a French national survey. Acta Derm Venereol. 2015;95(3):326\u20138.","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"718_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/bjd.16882","volume":"180","author":"J Mazereeuw-Hautier","year":"2019","unstructured":"Mazereeuw-Hautier J, Hern\u00e1ndez-Mart\u00edn A, O\u2019Toole EA, Bygum A, Amaro C, Aldwin M, et al. Management of congenital ichthyoses: European guidelines of care, part two. Br J Dermatol. 2019;180(3):484\u201395. https:\/\/doi.org\/10.1111\/bjd.16882.","journal-title":"Br J Dermatol"},{"issue":"5","key":"718_CR5","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1136\/bjophthalmol-2017-310615","volume":"102","author":"R Malhotra","year":"2018","unstructured":"Malhotra R, Hern\u00e1ndez-Mart\u0131n A, Oji V. Ocular manifestations, complications and management of congenital ichthyoses: a new look. Br J Ophthalmol. 2018;102(5):586. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310615.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"718_CR6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/BF00128954","volume":"15","author":"M Elshtewi","year":"1991","unstructured":"Elshtewi M, Archer DB. Congenital ichthyosis in a Libyan child with ophthalmic manifestations. Int Ophthalmol. 1991;15(5):343\u20135. https:\/\/doi.org\/10.1007\/BF00128954.","journal-title":"Int Ophthalmol"},{"issue":"2","key":"718_CR7","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/bjd.13710","volume":"173","author":"AS Litwin","year":"2015","unstructured":"Litwin AS, Kalantzis G, Drimtzias E, Hamada S, Chang B, Malhotra R. Nonsurgical treatment of congenital ichthyosis cicatricial ectropion and eyelid retraction using Restylane hyaluronic acid. Br J Dermatol. 2015;173(2):601\u20133. https:\/\/doi.org\/10.1111\/bjd.13710.","journal-title":"Br J Dermatol"},{"issue":"12","key":"718_CR8","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1001\/archopht.1990.01070140126044","volume":"108","author":"JH Oestreicher","year":"1990","unstructured":"Oestreicher JH, Nelson CC. Lamellar ichthyosis and congenital ectropion. Arch Ophthalmol. 1990;108(12):1772\u20133. https:\/\/doi.org\/10.1001\/archopht.1990.01070140126044.","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"718_CR9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s00347-005-1279-2","volume":"103","author":"TB Menke","year":"2006","unstructured":"Menke TB, Moschner S, Joachimmeyer E, Ahrens P, Geerling G. Congenital ectropion in ichthyosis congenita mitis and gravis. Der Ophthalmol. 2006;103(5):410.","journal-title":"Der Ophthalmol."},{"issue":"4","key":"718_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1525-1470.2011.01375.x","volume":"28","author":"A Bassotti","year":"2011","unstructured":"Bassotti A, Moreno S, Criado E. Successful treatment with topical N-acetylcysteine in urea in five children with congenital lamellar ichthyosis. Pediatr Dermatol. 2011;28(4):451\u20135. https:\/\/doi.org\/10.1111\/j.1525-1470.2011.01375.x.","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"718_CR11","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0181-5512(05)81074-5","volume":"28","author":"JJ Gicquel","year":"2005","unstructured":"Gicquel JJ, Vabres P, Dighiero P. Use of topical cutaneous N-acetylcysteine in the treatment of major bilateral ectropion in an infant with lamellar ichthyosis. J F Ophtalmol. 2005;28(4):412\u20135.","journal-title":"J F Ophtalmol."},{"issue":"5","key":"718_CR12","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/pde.13240","volume":"34","author":"B Hanson","year":"2017","unstructured":"Hanson B, Becker L, Hook K, Polcari I, Areaux RG Jr, Maguiness S. Ectropion improvement with topical tazarotene in children with lamellar ichthyosis. Pediatr Dermatol. 2017;34(5):584\u20139. https:\/\/doi.org\/10.1111\/pde.13240.","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"718_CR13","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1001\/jamadermatol.2013.239","volume":"149","author":"BG Craiglow","year":"2013","unstructured":"Craiglow BG, Choate KA, Milstone LM. Topical tazarotene for the treatment of ectropion in ichthyosis. JAMA Dermatol. 2013;149(5):598\u2013600. https:\/\/doi.org\/10.1001\/jamadermatol.2013.239.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"718_CR14","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1111\/pde.13410","volume":"35","author":"M Singh","year":"2018","unstructured":"Singh M, Kaur M, Kaur R, Singh S. Severe ectropion in lamellar ichthyosis managed medically with oral acitretin. Pediatr Dermatol. 2018;35(2):e117\u201320. https:\/\/doi.org\/10.1111\/pde.13410.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"718_CR15","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-1313","volume":"137","author":"G Sethuraman","year":"2016","unstructured":"Sethuraman G, Marwaha RK, Challa A, Yenamandra VK, Ramakrishnan L, Thulkar S, et al. Vitamin D: a new promising therapy for congenital ichthyosis. Pediatrics. 2016;137(1): e20151313. https:\/\/doi.org\/10.1542\/peds.2015-1313.","journal-title":"Pediatrics"},{"issue":"5","key":"718_CR16","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1097\/IOP.0000000000000287","volume":"32","author":"H Sigurdsson","year":"2016","unstructured":"Sigurdsson H, Baldursson BT. Inverting sutures with systemic retinoids and lubrication can correct ectropion in ichthyosis. Ophthalmic Plast Reconstr Surg. 2016;32(5):e112\u20133.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"3","key":"718_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000001047","volume":"34","author":"J-PJ Abboud","year":"2018","unstructured":"Abboud J-PJ, Whittington A, Ahmed M, Himebaugh JT, Wiley LA, Haffar A, et al. Apremilast use in a case of cicatricial ectropion secondary to severe lamellar ichthyosis. Ophthalmic Plastic Reconstr Surg. 2018;34(3): e76.","journal-title":"Ophthalmic Plastic Reconstr Surg."},{"issue":"4","key":"718_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/IOP.0b013e3181ac984b","volume":"25","author":"M Taban","year":"2009","unstructured":"Taban M, Mancini R, Nakra T, Velez FG, Ela-Dalman N, Tsirbas A, et al. Nonsurgical management of congenital eyelid malpositions using hyaluronic acid gel. Ophthalmic Plast Reconstr Surg. 2009;25(4):259\u201363. https:\/\/doi.org\/10.1097\/IOP.0b013e3181ac984b.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"3","key":"718_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3109\/2000656X.2013.842923","volume":"48","author":"MG Zachara","year":"2014","unstructured":"Zachara MG, Drozdowski PH, \u0141\u0105tkowski IT. Surgical management of ichtyosis-related ectropion. Description of four cases and a literature review. J Plastic Surg Hand Surg. 2014;48(3):179\u201382. https:\/\/doi.org\/10.3109\/2000656X.2013.842923.","journal-title":"J Plastic Surg Hand Surg."},{"issue":"1","key":"718_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/IOP.0b013e3181b8e0d4","volume":"26","author":"S Das","year":"2010","unstructured":"Das S, Honavar SG, Dhepe N, Naik MN. Maternal skin allograft for cicatricial ectropion in congenital icthyosis. Ophthalmic Plast Reconstr Surg. 2010;26(1):42\u20133.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"3","key":"718_CR21","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S0002-9394(02)01567-2","volume":"134","author":"SM Culican","year":"2002","unstructured":"Culican SM, Custer PL. Repair of cicatricial ectropion in an infant with harlequin ichthyosis using engineered human skin. Am J Ophthalmol. 2002;134(3):442\u20133. https:\/\/doi.org\/10.1016\/S0002-9394(02)01567-2.","journal-title":"Am J Ophthalmol."},{"issue":"1","key":"718_CR22","doi-asserted-by":"publisher","first-page":"NP7","DOI":"10.1177\/1120672118805622","volume":"30","author":"MV Cicinelli","year":"2020","unstructured":"Cicinelli MV, Dave TV, Madhuri BK, Tiple S, Naik MN. Non-surgical management of congenital ichthyosis using hyaluronic acid gel injection. Eur J Ophthalmol. 2020;30(1):NP7\u201310. https:\/\/doi.org\/10.1177\/1120672118805622.","journal-title":"Eur J Ophthalmol."},{"issue":"2","key":"718_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3315\/jdcr.2011.1068","volume":"5","author":"OR Ozgur","year":"2011","unstructured":"Ozgur OR, Akcay L, Tutas N, Ozkurt Y. Cicatricial upper and lower eyelid ectropion in an ichthyosis patient. Surgical correction. J Dermatol Case Rep. 2011;5(2):27\u20139. https:\/\/doi.org\/10.3315\/jdcr.2011.1068.","journal-title":"J Dermatol Case Rep."},{"key":"718_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ijscr.2017.02.008","volume":"33","author":"HM Alkatan","year":"2017","unstructured":"Alkatan HM, Aljebreen MA, Alsuhaibani AH. Long term follow up of mucous membrane grafting for cicatricial ectropion in Ichthyosis: a case report. Int J Surg Case Rep. 2017;33:21\u20133. https:\/\/doi.org\/10.1016\/j.ijscr.2017.02.008.","journal-title":"Int J Surg Case Rep"},{"issue":"6","key":"718_CR25","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1097\/IOP.0b013e3182082f4e","volume":"27","author":"S Nayak","year":"2011","unstructured":"Nayak S, Rath S, Kar BR. Mucous membrane graft for cicatricial ectropion in lamellar ichthyosis: An approach revisited. Ophthalmic Plast Reconstr Surg. 2011;27(6):e155\u20136. https:\/\/doi.org\/10.1097\/IOP.0b013e3182082f4e.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"11","key":"718_CR26","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/S0161-6420(01)00785-0","volume":"108","author":"CNS Soparkar","year":"2001","unstructured":"Soparkar CNS, Patrinely JR, Hunt MG, Shenaq SM. Transforming mucous membrane grafts into skin grafts. Ophthalmology. 2001;108(11):1933\u20134. https:\/\/doi.org\/10.1016\/S0161-6420(01)00785-0.","journal-title":"Ophthalmology"},{"issue":"1","key":"718_CR27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2340\/00015555-0415","volume":"88","author":"A Vahlquist","year":"2008","unstructured":"Vahlquist A, G\u00e5nemo A, Virtanen M. Congenital ichthyosis: an overview of current and emerging therapies. Acta Derm Venereol. 2008;88(1):4\u201314. https:\/\/doi.org\/10.2340\/00015555-0415.","journal-title":"Acta Derm Venereol"},{"issue":"5 Suppl","key":"718_CR28","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1016\/j.jaad.2006.05.028","volume":"57","author":"V Nguyen","year":"2007","unstructured":"Nguyen V, Cunningham BB, Eichenfield LF, Alio AB, Buka RL. Treatment of ichthyosiform diseases with topically applied tazarotene: risk of systemic absorption. J Am Acad Dermatol. 2007;57(5 Suppl):S123\u20135.","journal-title":"J Am Acad Dermatol"},{"key":"718_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-019-01994-x","author":"H Cort\u00e9s","year":"2019","unstructured":"Cort\u00e9s H, Del Prado-Audelo ML, Urb\u00e1n-Morl\u00e1n Z, Alcal\u00e1-Alcal\u00e1 S, Gonz\u00e1lez-Torres M, Reyes-Hern\u00e1ndez OD, et al. Pharmacological treatments for cutaneous manifestations of inherited ichthyoses. Arch Dermatol Res. 2019. https:\/\/doi.org\/10.1007\/s00403-019-01994-x.","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"718_CR30","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1016\/j.jaad.2014.04.010","volume":"71","author":"M Ogawa","year":"2014","unstructured":"Ogawa M, Akiyama M. Successful topical adapalene treatment for the facial lesions of an adolescent case of epidermolytic ichthyosis. J Am Acad Dermatol. 2014;71(3):e103\u20135. https:\/\/doi.org\/10.1016\/j.jaad.2014.04.010.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"718_CR31","first-page":"346","volume":"85","author":"C Cotellessa","year":"2005","unstructured":"Cotellessa C, Cuevas-Covarrubias SA, Valeri P, Fargnoli MC, Peris K. Topical tazarotene 0.05% versus glycolic acid 70% treatment in X-linked ichthyosis due to extensive deletion of the STS gene. Acta Dermato-Venereol. 2005;85(4):346\u20138.","journal-title":"Acta Dermato-Venereol."},{"issue":"4","key":"718_CR32","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1046\/j.1365-2133.1999.03101.x","volume":"141","author":"S Hofmann","year":"1999","unstructured":"Hofmann S, Ruzicka L. Effect of topical tazarotene in the treatment of congenital ichthyoses. Br J Dermatol. 1999;141(4):642\u20136. https:\/\/doi.org\/10.1046\/j.1365-2133.1999.03101.x.","journal-title":"Br J Dermatol"},{"issue":"5, Supplement","key":"718_CR33","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.jaad.2005.09.018","volume":"55","author":"RV Kundu","year":"2006","unstructured":"Kundu RV, Garg A, Worobec SM. Lamellar ichthyosis treated with tazarotene 0.1% gel. J Am Acad Dermatol. 2006;55(5, Supplement):S94\u20135. https:\/\/doi.org\/10.1016\/j.jaad.2005.09.018.","journal-title":"J Am Acad Dermatol."},{"key":"718_CR34","first-page":"121","volume-title":"Mendelian disorders of cornification (MEDOC): the ichthyoses","author":"D Hohl","year":"2011","unstructured":"Hohl D, Williams M. Mendelian disorders of cornification (MEDOC): the ichthyoses. Oxford: Wiley-Blackwell; 2011. p. 121\u201370."},{"issue":"1","key":"718_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4103\/0378-6323.19718","volume":"72","author":"S Rajiv","year":"2006","unstructured":"Rajiv S, Rakhesh SV. Ichthyosis bullosa of Siemens: response to topical tazarotene. Indian J Dermatol Venereol Leprol. 2006;72(1):43.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5","key":"718_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12516","volume":"30","author":"B Behera","year":"2017","unstructured":"Behera B, Chandrashekar L, Singh N, Thappa DM, Gochhait D. Lamellar ichthyosis associated bilateral pseudoainhum of fingers and toes successfully treated with tazarotene. Dermatol Ther. 2017;30(5): e12516. https:\/\/doi.org\/10.1111\/dth.12516.","journal-title":"Dermatol Ther"},{"issue":"6","key":"718_CR37","first-page":"713","volume":"9","author":"RH Liu","year":"2010","unstructured":"Liu RH, Becker B, Gunkel J, Teng J. Rapid improvement in digital ischemia and acral contracture in a collodion baby treated with topical tazarotene. J Drugs Dermatol. 2010;9(6):713\u20136.","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"718_CR38","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1365-2133.2005.06399.x","volume":"152","author":"GPH Lucker","year":"2005","unstructured":"Lucker GPH, Verfaille CJ, Heremans AMC, Vanhoutte FP, Boegheim JPJ, Steijlen PPM. Topical liarozole in ichthyosis: a double-blind, left\u2013right comparative study followed by a long-term open maintenance study. Br J Dermatol. 2005;152(3):566\u20139. https:\/\/doi.org\/10.1111\/j.1365-2133.2005.06399.x.","journal-title":"Br J Dermatol"},{"issue":"1","key":"718_CR39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jid.2020.05.090","volume":"141","author":"JGS Veit","year":"2021","unstructured":"Veit JGS, De Glas V, Balau B, Liu H, Bourlond F, Paller AS, et al. Characterization of CYP26B1-selective inhibitor, DX314, as a potential therapeutic for keratinization disorders. J Invest Dermatol. 2021;141(1):72\u201383. https:\/\/doi.org\/10.1016\/j.jid.2020.05.090.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"718_CR40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3390\/biomedicines9030237","volume":"9","author":"T Cosio","year":"2021","unstructured":"Cosio T, Di Prete M, Gaziano R, Lanna C, Orlandi A, Di Francesco P, et al. Trifarotene: a current review and perspectives in dermatology. Biomedicines. 2021;9(3):237. https:\/\/doi.org\/10.3390\/biomedicines9030237.","journal-title":"Biomedicines."},{"key":"718_CR41","unstructured":"Pharmaceuticals T. Timber Pharmaceuticals Receives FDA Breakthrough Therapy Designation for TMB-001 for the Treatment of Congenital Ichthyosis 2022. 2022. https:\/\/www-timberpharma-com.filesusr.com\/html\/e02db4_e15c6b0a9f8074ab103c2ddcbe952e41.html?qmodStoryID=7129573901766610."},{"issue":"4","key":"718_CR42","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/s0738-081x(03)00051-8","volume":"21","author":"N Rubeiz","year":"2003","unstructured":"Rubeiz N, Kibbi A-G. Management of ichthyosis in infants and children. Clin Dermatol. 2003;21(4):325\u20138. https:\/\/doi.org\/10.1016\/s0738-081x(03)00051-8.","journal-title":"Clin Dermatol"},{"issue":"5","key":"718_CR43","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1001\/archderm.1995.01690170058008","volume":"131","author":"K Kragballe","year":"1995","unstructured":"Kragballe K, Steijlen PM, Ibsen H, et al. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization: results of a randomized, double-blind, vehicle-controlled, right\/left comparative study. Arch Dermatol. 1995;131(5):556\u201360. https:\/\/doi.org\/10.1001\/archderm.1995.01690170058008.","journal-title":"Arch Dermatol"},{"issue":"4","key":"718_CR44","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1365-2133.1994.tb08558.x","volume":"131","author":"GPH Lucker","year":"1994","unstructured":"Lucker GPH, Van de Kerkhof PCM, Van Dijk MR, Steijlen PM. Effect of topical calcipotriol on congenital ichthyoses. Br J Dermatol. 1994;131(4):546\u201350.","journal-title":"Br J Dermatol"},{"issue":"6","key":"718_CR45","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1346-8138.2006.00102.x","volume":"33","author":"Y Mizuno","year":"2006","unstructured":"Mizuno Y, Suga Y, Hasegawa T, Haruna K, Kohroh K, Ogawa H, et al. A case of peeling skin syndrome successfully treated with topical calcipotriol. J Dermatol. 2006;33(6):430\u20132. https:\/\/doi.org\/10.1111\/j.1346-8138.2006.00102.x.","journal-title":"J Dermatol"},{"issue":"3","key":"718_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.5070\/D39S23V2M9","volume":"16","author":"K Garg","year":"2010","unstructured":"Garg K, Singh D, Mishra D. Peeling skin syndrome: current status. Dermatol Online J. 2010;16(3):10.","journal-title":"Dermatol Online J"},{"issue":"1","key":"718_CR47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/00015550310002738","volume":"83","author":"T Bogenrieder","year":"2003","unstructured":"Bogenrieder T, Landthaler M, Stolz W. Bullous congenital ichthyosiform erythroderma: safe and effective topical treatment with calcipotriol ointment in a child. Acta Derm Venereol. 2003;83(1):52\u20134.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"718_CR48","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1365-2230.2008.02761.x","volume":"33","author":"A Umekoji","year":"2008","unstructured":"Umekoji A, Fukai K, Ishii M. A case of mosaic-type bullous congenital ichthyosiform erythroderma successfully treated with topical maxacalcitol, a vitamin D3 analogue. Clin Exp Dermatol (Print). 2008;33(4):501\u20132.","journal-title":"Clin Exp Dermatol (Print)."},{"issue":"1","key":"718_CR49","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40257-017-0313-x","volume":"19","author":"A Vahlquist","year":"2018","unstructured":"Vahlquist A, Fischer J, T\u00f6rm\u00e4 H. Inherited nonsyndromic ichthyoses: an update on pathophysiology, diagnosis and treatment. Am J Clin Dermatol. 2018;19(1):51\u201366. https:\/\/doi.org\/10.1007\/s40257-017-0313-x.","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"718_CR50","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/pde.13489","volume":"35","author":"L Kaplan","year":"2018","unstructured":"Kaplan L, Castelo-Soccio L. Topical N-acetylcysteine in ichthyosis: experience in 18 patients. Pediatr Dermatol. 2018;35(4):528\u201330. https:\/\/doi.org\/10.1111\/pde.13489.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"718_CR51","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/pde.12305","volume":"31","author":"P Davila-Seijo","year":"2014","unstructured":"Davila-Seijo P, Fl\u00f3rez A, Davila-Pousa C, No N, Ferreira C, De la Torre C. Topical N-acetylcysteine for the treatment of lamellar ichthyosis: an improved formula. Pediatr Dermatol. 2014;31(3):395\u20137. https:\/\/doi.org\/10.1111\/pde.12305.","journal-title":"Pediatr Dermatol"},{"key":"718_CR52","first-page":"245","volume":"45","author":"S\u00dc Sar\u00fdc\u00fd","year":"2003","unstructured":"Sar\u00fdc\u00fd S\u00dc, \u00deahin M, Yurdak\u00f6k M. Topical N-acetylcysteine treatment in neonatal ichthyosis. Turk J Pediatr. 2003;45:245\u20137.","journal-title":"Turk J Pediatr"},{"issue":"6","key":"718_CR53","doi-asserted-by":"publisher","first-page":"e357","DOI":"10.1111\/pde.13638","volume":"35","author":"A Batalla","year":"2018","unstructured":"Batalla A, D\u00e1vila-Pousa C, Feal C, Fl\u00f3rez \u00c1. Topical carbocysteine: a new option for the treatment of ichthyosis. Pediatr Dermatol. 2018;35(6):e357\u20139. https:\/\/doi.org\/10.1111\/pde.13638.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"718_CR54","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/000155501750376221","volume":"81","author":"M Virtanen","year":"2001","unstructured":"Virtanen M, Gedde-Dahl T, Mork N-J, Leigh I, Bowden PE, Vahlquist A. Phenotypic\/genotypic correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy on keratin expression. Acta Derm Venereol. 2001;81(3):163\u201370. https:\/\/doi.org\/10.1080\/000155501750376221.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"718_CR55","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1529-8019.2012.01527.x","volume":"26","author":"JJ DiGiovanna","year":"2013","unstructured":"DiGiovanna JJ, Mauro T, Milstone LM, Schmuth M, Toro JR. Systemic retinoids in the management of ichthyoses and related skin types. Dermatol Ther. 2013;26(1):26\u201338. https:\/\/doi.org\/10.1111\/j.1529-8019.2012.01527.x.","journal-title":"Dermatol Ther"},{"issue":"2","key":"718_CR56","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1365-2133.2005.06906.x","volume":"154","author":"RP Katugampola","year":"2006","unstructured":"Katugampola RP, Finlay AY. Oral retinoid therapy for disorders of keratinization: single-centre retrospective 25 years\u2019 experience on 23 patients. Br J Dermatol. 2006;154(2):267\u201376. https:\/\/doi.org\/10.1111\/j.1365-2133.2005.06906.x.","journal-title":"Br J Dermatol"},{"issue":"4 Suppl 1","key":"718_CR57","doi-asserted-by":"publisher","first-page":"S72","DOI":"10.1590\/S0365-05962011000700018","volume":"86","author":"PW Nassif","year":"2011","unstructured":"Nassif PW, Nakandakari S, Fogagnolo L, Contin LA, Alves C. Epidermolytic hyperkeratosis: a follow-up of 23 years of use of systemic retinoids. An Bras Dermatol. 2011;86(4 Suppl 1):S72\u20135.","journal-title":"An Bras Dermatol"},{"issue":"2","key":"718_CR58","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1365-2230.2007.02531.x","volume":"33","author":"AE Macbeth","year":"2008","unstructured":"Macbeth AE, Johnston GA. Twenty-one years of oral retinoid therapy in siblings with nonbullous ichthyosiform erythroderma. Clin Exp Dermatol Clin Dermatol. 2008;33(2):190\u20131.","journal-title":"Clin Exp Dermatol Clin Dermatol."},{"issue":"5","key":"718_CR59","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1365-2133.2006.07745.x","volume":"156","author":"C Verfaille","year":"2007","unstructured":"Verfaille C, Vanhoutte F, Blanchet-Bardon C, Van Steensel M, Steijlen P. Oral liarozole vs. acitretin in the treatment of ichthyosis: a phase II\/III multicentre, double-blind, randomized, active-controlled study. Br J Dermatol. 2007;156(5):965\u201373.","journal-title":"Br J Dermatol"},{"issue":"1","key":"718_CR60","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/bjd.12626","volume":"170","author":"A Vahlquist","year":"2014","unstructured":"Vahlquist A, Blockhuys S, Steijlen P, van Rossem K, Didona B, Blanco D, et al. Oral liarozole in the treatment of patients with moderate\/severe lamellar ichthyosis: results of a randomized, double-blind, multinational, placebo-controlled phase II\/III trial. Br J Dermatol. 2014;170(1):173\u201381. https:\/\/doi.org\/10.1111\/bjd.12626.","journal-title":"Br J Dermatol"},{"issue":"5","key":"718_CR61","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1610-0387.2007.06541.x","volume":"6","author":"CJ Verfaille","year":"2008","unstructured":"Verfaille CJ, Borgers M, van Steensel MA. Retinoic acid metabolism blocking agents (RAMBAs): a new paradigm in the treatment of hyperkeratotic disorders. J German Soc Dermatol. 2008;6(5):355\u201364. https:\/\/doi.org\/10.1111\/j.1610-0387.2007.06541.x.","journal-title":"J German Soc Dermatol."},{"issue":"7","key":"718_CR62","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1046\/j.1365-4362.2001.01173.x","volume":"40","author":"S Singh","year":"2001","unstructured":"Singh S, Bhura M, Maheshwari A, Kumar A, Singh CP, Pandey SS. Successful treatment of harlequin ichthyosis with acitretin. Int J Dermatol. 2001;40(7):472\u20133. https:\/\/doi.org\/10.1046\/j.1365-4362.2001.01173.x.","journal-title":"Int J Dermatol"},{"issue":"6","key":"718_CR63","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/archdermatol.2011.9","volume":"147","author":"S Rajpopat","year":"2011","unstructured":"Rajpopat S, Moss C, Mellerio J, Vahlquist A, G\u00e5nemo A, Hellstrom-Pigg M, et al. Harlequin ichthyosis: a review of clinical and molecular findings in 45 cases. Arch Dermatol. 2011;147(6):681\u20136. https:\/\/doi.org\/10.1001\/archdermatol.2011.9.","journal-title":"Arch Dermatol"},{"issue":"4","key":"718_CR64","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.1111\/pde.12614","volume":"32","author":"S Neema","year":"2015","unstructured":"Neema S, Mukherjee S, Vasudevan B, Verma R, Moorchung N, Chatterjee M. Vitamin D deficiency after oral retinoid therapy for ichthyosis. Pediatr Dermatol. 2015;32(4):e151\u20135. https:\/\/doi.org\/10.1111\/pde.12614.","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"718_CR65","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000102043","volume":"215","author":"F ten Katharina","year":"2007","unstructured":"ten Katharina F, Hans-Wilhelm K, Proelss J, T\u00fcting T, Bieber T, Wenzel J. Successful treatment of bullous congenital ichthyosiform erythroderma with erythromycin. Dermatology. 2007;215(1):81\u20133.","journal-title":"Dermatology"},{"issue":"1","key":"718_CR66","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jaci.2016.07.019","volume":"139","author":"AS Paller","year":"2016","unstructured":"Paller AS, Renert-Yuval Y, Suprun M, Esaki H, Oliva M, Huynh TN, et al. An IL-17-dominant immune profile is shared across the major orphan forms of ichthyosis. J Allergy Clin Immunol. 2016;139(1):152\u201365. https:\/\/doi.org\/10.1016\/j.jaci.2016.07.019.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"718_CR67","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jaci.2018.03.021","volume":"143","author":"K Malik","year":"2019","unstructured":"Malik K, He H, Huynh TN, Tran G, Mueller K, Doytcheva K, et al. Ichthyosis molecular fingerprinting shows profound TH17 skewing and a unique barrier genomic signature. J Allergy Clin Immunol. 2019;143(2):604\u201318. https:\/\/doi.org\/10.1016\/j.jaci.2018.03.021.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"718_CR68","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1016\/j.jid.2018.03.1523","volume":"138","author":"T Czarnowicki","year":"2018","unstructured":"Czarnowicki T, He H, Leonard A, Malik K, Magidi S, Rangel S, et al. The major orphan forms of ichthyosis are characterized by systemic T-cell activation and Th-17\/Tc-17\/Th-22\/Tc-22 polarization in blood. J Investig Dermatol. 2018;138(10):2157\u201367. https:\/\/doi.org\/10.1016\/j.jid.2018.03.1523.","journal-title":"J Investig Dermatol."},{"issue":"4","key":"718_CR69","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.jaci.2022.02.010","volume":"149","author":"M Akiyama","year":"2022","unstructured":"Akiyama M. Understanding immune profiles in ichthyosis may lead to novel therapeutic targets. J Allergy Clin Immunol. 2022;149(4):1210\u20132. https:\/\/doi.org\/10.1016\/j.jaci.2022.02.010.","journal-title":"J Allergy Clin Immunol"},{"key":"718_CR70","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.1018","author":"AS Paller","year":"2020","unstructured":"Paller AS. Pathogenesis-based therapy with repurposed biologics for monogenic inflammatory skin disorders. JAMA Dermatol. 2020. https:\/\/doi.org\/10.1001\/jamadermatol.2020.1018.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"718_CR71","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/ddg.13716","volume":"17","author":"D Haiges","year":"2019","unstructured":"Haiges D, Fischer J, H\u00f6rer S, Has C, Schempp CM. Biologic therapy targeting IL-17 ameliorates a case of congenital ichthyosiform cornification disorder. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 2019;17(1):70\u20132. https:\/\/doi.org\/10.1111\/ddg.13716.","journal-title":"JDDG Journal der Deutschen Dermatologischen Gesellschaft."},{"issue":"6","key":"718_CR72","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/pde.13995","volume":"36","author":"C Poulton","year":"2019","unstructured":"Poulton C, Gration D, Murray K, Baynam G, Halbert A. Autosomal recessive congenital ichthyosis due to homozygous variants in NIPAL4 with a dramatic response to ustekinumab. Pediatr Dermatol. 2019;36(6):1002\u20133. https:\/\/doi.org\/10.1111\/pde.13995.","journal-title":"Pediatr Dermatol"},{"key":"718_CR73","doi-asserted-by":"crossref","unstructured":"Lefferdink R, Rangel SM, Chima M, Ibler E, Pavel AB, Kim H, et al. Secukinumab responses vary across the spectrum of congenital ichthyosis in adults. Arch Dermatol Res. 2022:1\u201311.","DOI":"10.1007\/s00403-022-02325-3"},{"issue":"2","key":"718_CR74","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/hmg\/ddu459","volume":"24","author":"DL Cottle","year":"2015","unstructured":"Cottle DL, Ursino GMA, Ip SCI, Jones LK, Ditommaso T, Hacking DF, et al. Fetal inhibition of inflammation improves disease phenotypes in harlequin ichthyosis. Hum Mol Genet. 2015;24(2):436\u201349. https:\/\/doi.org\/10.1093\/hmg\/ddu459.","journal-title":"Hum Mol Genet"},{"issue":"13","key":"718_CR75","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1093\/hmg\/ddq145","volume":"19","author":"RFL O'Shaughnessy","year":"2010","unstructured":"O\u2019Shaughnessy RFL, Choudhary I, Harper JI. Interleukin-1 alpha blockade prevents hyperkeratosis in an in vitro model of lamellar ichthyosis. Hum Mol Genet. 2010;19(13):2594\u2013605. https:\/\/doi.org\/10.1093\/hmg\/ddq145.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"718_CR76","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1038\/jid.2011.189","volume":"131","author":"AS Paller","year":"2011","unstructured":"Paller AS, van Steensel MA, Rodriguez-Martin M, Sorrell J, Heath C, Crumrine D, et al. Pathogenesis-based therapy reverses cutaneous abnormalities in an inherited disorder of distal cholesterol metabolism. J Invest Dermatol. 2011;131(11):2242\u20138. https:\/\/doi.org\/10.1038\/jid.2011.189.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"718_CR77","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/ajmg.a.38619","volume":"176","author":"C Bergqvist","year":"2018","unstructured":"Bergqvist C, Abdallah B, Hasbani DJ, Abbas O, Kibbi AG, Hamie L, et al. CHILD syndrome: a modified pathogenesis-targeted therapeutic approach. Am J Med Genet A. 2018;176(3):733\u20138. https:\/\/doi.org\/10.1002\/ajmg.a.38619.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"718_CR78","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1529-8019.2012.01528.x","volume":"26","author":"JE Lai-Cheong","year":"2013","unstructured":"Lai-Cheong JE, Elias PM, Paller AS. Pathogenesis-based therapies in ichthyoses. Dermatol Ther. 2013;26(1):46\u201354. https:\/\/doi.org\/10.1111\/j.1529-8019.2012.01528.x.","journal-title":"Dermatol Ther"},{"issue":"2","key":"718_CR79","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1006\/excr.1993.1326","volume":"209","author":"TG Jensen","year":"1993","unstructured":"Jensen TG, Jensen UB, Jensen PKA, Ibsen HH, Brandrup F, Ballabio A, et al. Correction of steroid sulfatase deficiency by gene transfer into basal cells of tissue-cultured epidermis from patients with recessive X-linked ichthyosis. Exp Cell Res. 1993;209(2):392\u20137. https:\/\/doi.org\/10.1006\/excr.1993.1326.","journal-title":"Exp Cell Res"},{"issue":"6","key":"718_CR80","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/hmg\/6.6.927","volume":"6","author":"RA Freiberg","year":"1997","unstructured":"Freiberg RA, Choate KA, Deng H, Alperin ES, Shapiro LJ, Khavari PA. A model of corrective gene transfer in X-linked ichthyosis. Hum Mol Genet. 1997;6(6):927\u201333. https:\/\/doi.org\/10.1093\/hmg\/6.6.927.","journal-title":"Hum Mol Genet"},{"issue":"7","key":"718_CR81","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1038\/jid.2012.65","volume":"132","author":"K Aufenvenne","year":"2012","unstructured":"Aufenvenne K, Rice RH, Hausser I, Oji V, Hennies HC, Rio MD, et al. Long-term faithful recapitulation of transglutaminase 1-deficient lamellar ichthyosis in a skin-humanized mouse model, and insights from proteomic studies. J Investig Dermatol. 2012;132(7):1918\u201321. https:\/\/doi.org\/10.1038\/jid.2012.65.","journal-title":"J Investig Dermatol."},{"issue":"4","key":"718_CR82","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.ajhg.2013.08.003","volume":"93","author":"K Aufenvenne","year":"2013","unstructured":"Aufenvenne K, Larcher F, Hausser I, Duarte B, Oji V, Nikolenko H, et al. Topical enzyme-replacement therapy restores transglutaminase 1 activity and corrects architecture of transglutaminase-1-deficient skin grafts. Am J Hum Genet. 2013;93(4):620\u201330. https:\/\/doi.org\/10.1016\/j.ajhg.2013.08.003.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"718_CR83","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.jid.2018.11.002","volume":"139","author":"R Plank","year":"2019","unstructured":"Plank R, Yealland G, Miceli E, Cunha DL, Graff P, Thomforde S, et al. Transglutaminase 1 replacement therapy successfully mitigates the autosomal recessive congenital ichthyosis phenotype in full-thickness skin disease equivalents. J Investig Dermatol. 2019;139(5):1191\u20135.","journal-title":"J Investig Dermatol"},{"key":"718_CR84","doi-asserted-by":"crossref","unstructured":"Plank R, Obst K, Yealland G, Calder\u00f3n M, Hedtrich S, Martina Eckl K, editors. Nanogel-mediated protein replacement therapy for autosomal recessive congenital ichthyosis (ARCI)2016.","DOI":"10.11159\/nddte16.105"},{"issue":"4","key":"718_CR85","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.jid.2020.07.035","volume":"141","author":"JC Freedman","year":"2021","unstructured":"Freedman JC, Parry TJ, Zhang P, Majumdar A, Krishnan S, Regula LK, et al. Preclinical evaluation of a modified herpes simplex virus type 1 vector encoding human TGM1 for the treatment of autosomal recessive congenital ichthyosis. J Investig Dermatol. 2021;141(4):874-82.e6. https:\/\/doi.org\/10.1016\/j.jid.2020.07.035.","journal-title":"J Investig Dermatol."},{"issue":"8","key":"718_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161465","volume":"11","author":"L Zhang","year":"2016","unstructured":"Zhang L, Ferreyros M, Feng W, Hupe M, Crumrine DA, Chen J, et al. Defects in stratum corneum desquamation are the predominant effect of impaired abca12 function in a novel mouse model of harlequin ichthyosis. PLoS ONE. 2016;11(8): e0161465-e. https:\/\/doi.org\/10.1371\/journal.pone.0161465.","journal-title":"PLoS ONE"},{"issue":"2","key":"718_CR87","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jid.2016.08.036","volume":"137","author":"S Grond","year":"2017","unstructured":"Grond S, Eichmann TO, Dubrac S, Kolb D, Schmuth M, Fischer J, et al. PNPLA1 deficiency in mice and humans\u00a0leads to a defect in the synthesis\u00a0of omega-O-acylceramides. J Investig Dermatol. 2017;137(2):394\u2013402. https:\/\/doi.org\/10.1016\/j.jid.2016.08.036.","journal-title":"J Investig Dermatol."},{"issue":"11","key":"718_CR88","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1001\/jamadermatol.2018.2904","volume":"154","author":"S Khalil","year":"2018","unstructured":"Khalil S, Bardawil T, Saade S, Chedraoui A, Ramadan N, Hasbani DJ, et al. Use of topical glycolic acid plus a lovastatin-cholesterol combination cream for the treatment of autosomal recessive congenital ichthyoses. JAMA Dermatol. 2018;154(11):1320\u20133. https:\/\/doi.org\/10.1001\/jamadermatol.2018.2904.","journal-title":"JAMA Dermatol"},{"key":"718_CR89","unstructured":"Cottle DL, Ursino GMA, Jones LK, Tham MS, Zylberberg AK, Smyth IM. Topical aminosalicylic acid improves keratinocyte differentiation in an inducible mouse model of harlequin ichthyosis. (2666\u20133791 (Electronic))."},{"issue":"11","key":"718_CR90","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/nm1196-1263","volume":"2","author":"JR Morgan","year":"1996","unstructured":"Morgan JR, Choate KA, Medalie DA, Khavari PA. Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nat Med. 1996;2(11):1263\u20137. https:\/\/doi.org\/10.1038\/nm1196-1263.","journal-title":"Nat Med"},{"issue":"4","key":"718_CR91","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a015149","volume":"4","author":"E Gorell","year":"2014","unstructured":"Gorell E, Nguyen N, Lane A, Siprashvili Z. Gene therapy for skin diseases. Cold Spring Harb Perspect Med. 2014;4(4): a015149.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"1","key":"718_CR92","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1529-8019.2012.01553.x","volume":"26","author":"G Richard","year":"2013","unstructured":"Richard G, Choate K, Milstone L, Bale S. Management of ichthyosis and related conditions gene-based diagnosis and emerging gene-based therapy. Dermatol Ther. 2013;26(1):55\u201368. https:\/\/doi.org\/10.1111\/j.1529-8019.2012.01553.x.","journal-title":"Dermatol Ther"},{"issue":"7","key":"718_CR93","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1172\/JCI24834","volume":"115","author":"M Akiyama","year":"2005","unstructured":"Akiyama M, Sugiyama-Nakagiri Y, Sakai K, McMillan JR, Goto M, Arita K, et al. Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer. J Clin Investig. 2005;115(7):1777\u201384.","journal-title":"J Clin Investig"},{"key":"718_CR94","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2147\/CCID.S166849","volume":"12","author":"DP Rout","year":"2019","unstructured":"Rout DP, Nair A, Gupta A, Kumar P. Epidermolytic hyperkeratosis: clinical update. Clin Cosmet Investig Dermatol. 2019;12:333.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"5","key":"718_CR95","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2133.1991.tb14776.x","volume":"125","author":"PM Steijlen","year":"1991","unstructured":"Steijlen PM, Van Doorkn-Greebe RJ, Happle R, Van de Kerkhof PCM. Ichthyosis bullosa of Siemens responds well to low-dosage oral retinoids. Br J Dermatol. 1991;125(5):469\u201371.","journal-title":"Br J Dermatol"},{"issue":"6","key":"718_CR96","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1111\/bjd.16570","volume":"178","author":"Y Ramot","year":"2018","unstructured":"Ramot Y, Ol\u00e1h A, Paus R. Cover image: neuroendocrine treatment of inherited keratin disorders by cannabinoids? Br J Dermatol. 2018;178(6):1469.","journal-title":"Br J Dermatol"},{"issue":"8","key":"718_CR97","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.jid.2019.03.1146","volume":"139","author":"OP March","year":"2019","unstructured":"March OP, Lettner T, Klausegger A, Ablinger M, Kocher T, Hainzl S, et al. Gene editing-mediated disruption of epidermolytic ichthyosis-associated KRT10 alleles restores filament stability in keratinocytes. J Investig Dermatol. 2019;139(8):1699-710.e6. https:\/\/doi.org\/10.1016\/j.jid.2019.03.1146.","journal-title":"J Investig Dermatol."},{"key":"718_CR98","unstructured":"Valentin FA-O, Wiegmann HA-O, Tarinski T, Nikolenko H, Traupe HA-O, Liebau EA-O, et al. Development of a pathogenesis-based therapy for peeling skin syndrome type 1. (1365\u20132133 (Electronic))."},{"issue":"4","key":"718_CR99","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1046\/j.1365-2230.2003.01318.x","volume":"28","author":"GC Marulli","year":"2003","unstructured":"Marulli GC, Campione E, Chimenti MS, Terrinoni A, Melino G, Bianchi L. Type I lamellar ichthyosis improved by tazarotene 0.1% gel. Clin Exp Dermatol. 2003;28(4):391\u20133. https:\/\/doi.org\/10.1046\/j.1365-2230.2003.01318.x.","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"718_CR100","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000247549","volume":"184","author":"S Cambiaghi","year":"1992","unstructured":"Cambiaghi S, Ermacora E. Antibiotic therapy in a boy affected by generalized epidermolytic hyperkeratosis. Dermatology. 1992;184(3):226. https:\/\/doi.org\/10.1159\/000247549.","journal-title":"Dermatology"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-022-00718-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-022-00718-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-022-00718-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T09:41:34Z","timestamp":1665999694000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-022-00718-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":100,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["718"],"URL":"https:\/\/doi.org\/10.1007\/s40257-022-00718-8","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]},"assertion":[{"value":"25 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No sources of funding were used to conduct this study or prepare this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no conflicts of interest to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\/publish"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"All authors contributed significantly to the concept and planning, drafting, and revision of the manuscript. All authors approved the final submitted version of the manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}